Under construction – not a live service
Sign in
Taking people in PortugalNo phase

Heart Changes After Endovascular Repair of the Aorta

Studies heart shape and function with MRI in adults after aortic repair.

Key facts

Who runs it
Lisbon Academic Medical Center - Centro Académico de Medicina de Lisboa
Where
Lisbon, PortugalSee the 2 sites
Trial code
Registry title
Cardiac Remodelling Following Endovascular Repair of the Aorta
Status
Recruiting
People taking part
40 people, planned
Started
1 Sept 2025
Expected to end
1 Sept 2027
Type of study
Observational
Treatments tested
  • cardiac magnetic ressonance
Record updated
17 February 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with certain aortic aneurysms, ulcers or hematomas who have a planned (elective) total endovascular aortic repair (EVAR). It studies the effect on heart shape and function.

Age
Over 18 years
Sex
All sexes
Disease stage
Degenerative arch, descending thoracic or abdominal aortic aneurysm, penetrating aortic ulcer or intramural hematoma, managed with total EVAR in an elective setting

Main reasons for not taking part

  • Heart failure with an ejection fraction <35 vs 50% or NYHA class III and IV
  • Moderate to severe valve disease
  • Coronary artery disease or atrial fibrillation
  • Cardiac or aortic surgery in the past or expected during the study
  • CMR contraindications such as non-compatible pacemakers, metal implants or claustrophobia

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Patients over 18-year-old, with degenerative arch, descending thoracic or abdominal aortic aneurysms, penetrating aortic ulcers or intramural hematomas managed with total EVAR in elective setting

Who cannot take part

  • CMR contraindications (non-compatible pacemakers and metal implants, and claustrophobia)
  • Moderate to severe valve disease
  • History of (or expected within the study period) cardiac/aortic surgery
  • Coronary artery disease
  • Congenital heart disease
  • Connective tissue disorders
  • Moderate to severe pulmonary disease as indicate either by post bronchodilator FEV1 (%predicted) <50% or Modified Medical Research Council Dyspnoea Scale (mMRC) 3-4
  • Heart failure with an ejection fraction <35 vs 50% or New York Heart Association (NYHA) class III and IV
  • Chronic kidney disease (eGFR <30 mL/min/173 m2)
  • LV wall motion abnormality
  • Atrial fibrillation

Where in Portugal

  • Unidade Local De Saude De Santa Maria E.P.E.Lisbon, PortugalContact: Augusto Ministro Augusto MinistroNot yet recruiting
  • Unidade Local de Saúde Santa MariaLisbon, PortugalContact: CICTaking people

About the trial

What the trial wants to find out

To assess the effects of endovascular aortic repair on cardiac morphology and function

The group in the trial

  • Participants submitted to aortic repair

    Participants submitted endovascular repair of the aorta

    Treatment: cardiac magnetic ressonance

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Cardiac Remodelling Following Endovascular Repair of the Aorta
Plain-language title
Heart Changes After Endovascular Repair of the AortaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 13 November 2026.
Record updated
17 February 2026